IN BRIEF: Ondine Biomedical secures CAD5 million financing
24th Sep 2024 16:20
Ondine Biomedical Inc - Vancouver-based company specialising in photodisinfection-based therapies to prevent and treat a broad spectrum of infections - Announces it has agreed to private placement financing in exchange for common shares from a third-party private investor in Canada to support commercial growth. Ondine will issue 22.2 million new common shares, raising CAD5 million - around GBP2.8 million - at 12.5 pence per share. Read More